These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


310 related items for PubMed ID: 34494842

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S, Kestur US, Flaherty DP, Taylor LS.
    Mol Pharm; 2020 Apr 06; 17(4):1261-1275. PubMed ID: 32134677
    [Abstract] [Full Text] [Related]

  • 5. Drug Release and Nanodroplet Formation from Amorphous Solid Dispersions: Insight into the Roles of Drug Physicochemical Properties and Polymer Selection.
    Yang R, Mann AKP, Van Duong T, Ormes JD, Okoh GA, Hermans A, Taylor LS.
    Mol Pharm; 2021 May 03; 18(5):2066-2081. PubMed ID: 33784104
    [Abstract] [Full Text] [Related]

  • 6. Dissolution Behavior of Weakly Basic Pharmaceuticals from Amorphous Dispersions Stabilized by a Poly(dimethylaminoethyl Methacrylate) Copolymer.
    Frank DS, Prasad P, Iuzzolino L, Schenck L.
    Mol Pharm; 2022 Sep 05; 19(9):3304-3313. PubMed ID: 35985017
    [Abstract] [Full Text] [Related]

  • 7. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S, Mugheirbi NA, Zemlyanov DY, Kestur US, Taylor LS.
    J Control Release; 2019 Mar 28; 298():68-82. PubMed ID: 30731151
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
    Purohit HS, Taylor LS.
    Pharm Res; 2017 Dec 28; 34(12):2842-2861. PubMed ID: 28956218
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Release Mechanisms of Amorphous Solid Dispersions: Role of Drug-Polymer Phase Separation and Morphology.
    Yang R, Zhang GGZ, Zemlyanov DY, Purohit HS, Taylor LS.
    J Pharm Sci; 2023 Jan 28; 112(1):304-317. PubMed ID: 36306863
    [Abstract] [Full Text] [Related]

  • 17. Dissolution Mechanisms of Amorphous Solid Dispersions: Role of Drug Load and Molecular Interactions.
    Deac A, Qi Q, Indulkar AS, Purohit HS, Gao Y, Zhang GGZ, Taylor LS.
    Mol Pharm; 2023 Jan 02; 20(1):722-737. PubMed ID: 36545917
    [Abstract] [Full Text] [Related]

  • 18. Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization.
    Moseson DE, Corum ID, Lust A, Altman KJ, Hiew TN, Eren A, Nagy ZK, Taylor LS.
    AAPS J; 2021 May 17; 23(4):69. PubMed ID: 34002256
    [Abstract] [Full Text] [Related]

  • 19. Pairwise polymer blends for oral drug delivery.
    Marks JA, Wegiel LA, Taylor LS, Edgar KJ.
    J Pharm Sci; 2014 Sep 17; 103(9):2871-2883. PubMed ID: 24823790
    [Abstract] [Full Text] [Related]

  • 20. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
    Baghel S, Cathcart H, O'Reilly NJ.
    Mol Pharm; 2018 Sep 04; 15(9):3796-3812. PubMed ID: 30020788
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.